TXG
10X Genomics Inc
Price:  
16.15 
USD
Volume:  
1,467,569.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TXG Relative Valuation

-403.9%
Upside

As of 2024-12-11, the Relative Valuation of 10X Genomics Inc (TXG) is (49.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.15 USD, the upside of 10X Genomics Inc based on Relative Valuation is -403.9%.

The range of the Relative Valuation is (46.03) - (50.34) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.5x - 33.6x 33.4x
Forward P/E multiples 30.4x - 33.4x 31.7x
Fair Price (46.03) - (50.34) (49.09)
Upside -385.0% - -411.7% -403.9%
16.15 USD
Stock Price
(49.09) USD
Fair Price

TXG Relative Valuation - Historical P/E Data

Date P/E
2024-12-02 -10.91
2024-11-29 -10.54
2024-11-27 -10.26
2024-11-26 -9.95
2024-11-25 -10.15
2024-11-22 -9.49
2024-11-21 -8.81
2024-11-20 -8.83
2024-11-19 -9.00
2024-11-18 -8.74
2024-11-15 -8.85
2024-11-14 -9.36
2024-11-13 -9.89
2024-11-12 -10.40
2024-11-11 -10.54
2024-11-08 -10.37
2024-11-07 -10.72
2024-11-06 -11.01
2024-11-05 -11.50
2024-11-04 -11.13
2024-11-01 -10.83
2024-10-31 -10.63
2024-10-30 -10.93
2024-10-29 -10.47
2024-10-28 -10.52
2024-10-25 -10.27
2024-10-24 -10.26
2024-10-23 -10.01
2024-10-22 -10.04
2024-10-21 -10.19
2024-10-18 -10.24
2024-10-17 -9.85
2024-10-16 -10.44
2024-10-15 -10.55
2024-10-14 -10.79
2024-10-11 -10.78
2024-10-10 -10.39
2024-10-09 -13.80
2024-10-08 -13.33
2024-10-07 -13.15
2024-10-04 -13.28
2024-10-03 -13.00
2024-10-02 -13.35
2024-10-01 -14.13
2024-09-30 -14.97
2024-09-27 -15.03
2024-09-26 -14.79
2024-09-25 -14.09
2024-09-24 -15.23
2024-09-23 -14.73